New breast cancer vaccine provides evidence of immunotherapy in preventing disease re

Phase I: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase II: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase III: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase IV: Studies are done after the drug or treatment has been marketed to gather information on the drug\'s effect in various populations and any side effects associated with long-term use.

'lizbeth · 09-08-2014, 01:58 PM

I liked this line:

Quote:

Women with HER2 +3 who were administered trastuzumab as part of the standard of care prior to receiving the vaccine experienced no cases of cancer recurrence.

So ladies, are we looking at high cure rates with these vaccines? It appears so. Not only the early stage Her2 3+ with GP2, but the subset of triple negative with low Her2 expression might also reach high cure rates with the E75. I expect good news from AE37 as well.

We lucky ladies who entered these trials need to stay in touch with the trial administrators. I personally would like to see data beyond 5 years.